FZD10-AS1: A Promising Drug Target and Biomarker (G440119)

Target Name: FZD10-AS1

NCBI ID: G440119

FZD10-AS1

Other Name(s): FZD10-DT | FZD10 antisense divergent transcript

FZD10-AS1: A Promising Drug Target and Biomarker

FZD10-AS1, also known as FZD10-DT, is a drug target and a potential biomarker for the treatment of various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study.

FZD10-AS1 is a small molecule that is derived from the combinatorial library of the National Library of Medicine (NLM). It has a unique molecular formula of C21H18N2O4 and a molecular weight of 374.34 grams per milliliter (g/ml). FZD10-AS1 is a white or almost white crystalline powder with a melting point of 110-115掳C.

FZD10-AS1 has been shown to interact with several protein targets, including the androgen receptor, the estrogen receptor, and the heat shock protein (HSP70). These interactions suggest that FZD10-AS1 may have potential as a drug or biomarker for the treatment of hormone-related diseases, such as prostate cancer and breast cancer.

FZD10-AS1 has also been shown to interact with the protein PD-L1, which is a known regulator of immune responses. This interaction suggests that FZD10-AS1 may have potential as a drug or biomarker for the treatment of immunological diseases, such as autoimmune diseases.

In addition to its potential as a drug or biomarker, FZD10-AS1 has also been shown to have potential as a research tool for the study of protein-protein interactions and protein structure-based design. Its unique molecular formula and structure make it an attractive target for the development of new drugs or biomarkers, as well as for the study of protein-protein interactions and structure-based design.

Overall, FZD10-AS1 is a promising drug target and biomarker with potential for the treatment of various diseases. Further research is needed to fully understand its unique properties and its potential as a drug or biomarker.

Protein Name: FZD10 Antisense Divergent Transcript

The "FZD10-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FZD10-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets